Tarriff Scott

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
24
Insider Sells Sum
$41.91M

Insider Activity of Tarriff Scott

According to the SEC Form 4 filings, Tarriff Scott, being in a position of

  1. CEO at Eagle Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 21619 shares for $299,309,
    over all time since 2015-03-20, has bought 0 shares, and sold 812273 shares for $41.91M.

The largest sale of all time was on 2015-03-20 and amounted to 240000 shares of Eagle Pharmaceuticals, Inc. for $10.08M.

Biography of Tarriff Scott

No biography is available at this moment.

2023-11-02SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
10,694
0.0805%
$13.87$148,326-65.26%
2023-11-01SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
10,925
0.0836%
$13.82$150,984-64.77%
2023-10-03SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
10,734
0.0786%
$14.46$155,174-64.53%
2023-10-02SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
9,511
0.0733%
$15.23$144,853-66.65%
2023-05-16SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
15,000
0.1151%
$19.98$299,700-55.02%
2023-05-15SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
15,000
0.1151%
$21.07$315,992-57.19%
2023-05-12SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
15,000
0.1131%
$20.27$304,014-54.2%
2023-05-11SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
15,000
0.1135%
$20.71$310,650-54.64%
2019-04-01SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
24,975
0.1811%
$50.15$1.25M+11.12%
2019-03-01SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
24,428
0.1732%
$51.17$1.25M+7.66%
2019-02-01SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
30,085
0.2144%
$41.54$1.25M+32.67%
2019-01-03SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
16,569
0.1199%
$39.29$651,058+40.87%
2019-01-02SaleEagle Pharmaceuticals, Inc.
EGRX
CEO
15,000
0.1051%
$39.71$595,705+34.8%
2016-04-01SaleEagle Pharmaceuticals, Inc.
EGRX
President and CEO
61,530
0.3931%
$40.63$2.5M+56.04%
2016-03-01SaleEagle Pharmaceuticals, Inc.
EGRX
President and CEO
39,560
0.238%
$63.20$2.5M-9.18%
2016-02-01SaleEagle Pharmaceuticals, Inc.
EGRX
President and CEO
36,720
0.2243%
$68.08$2.5M-15.04%
2016-01-04SaleEagle Pharmaceuticals, Inc.
EGRX
President and CEO
29,098
0.1856%
$85.91$2.5M-29.72%
2015-12-01SaleEagle Pharmaceuticals, Inc.
EGRX
President and CEO
28,100
0.1819%
$88.93$2.5M-32.79%
2015-11-02SaleEagle Pharmaceuticals, Inc.
EGRX
President and CEO
38,678
0.2367%
$64.63$2.5M-12.56%
2015-10-01SaleEagle Pharmaceuticals, Inc.
EGRX
President and CEO
35,756
0.224%
$69.92$2.5M-17.22%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.